ArticleReports of biochemistry & molecular biology2025
Methamphetamine-Induced Oxidative Stress and Inflammatory Markers as Indicators of Blood-Brain Barrier Disruption.
Article in Reports of biochemistry & molecular biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Methamphetamine (METH) abuse has been linked to neurotoxicity, oxidative stress, and dysfunction of the blood-brain barrier (BBB), potentially leading to cognitive impairments. This study aimed to evaluate the association between METH use, oxidative stress biomarkers, inflammation (NF-κB), endothelial permeability (MLCK), and memory impairment. Methods: A total of 150 male participants, aged 18-50 years, were recruited, including 75 METH users and 75 age-matched healthy controls. Serum levels of myosin light chain kinase (MLCK, NCBI Gene ID: 4638), nuclear factor kappa B (NF-κB, NCBI Gene ID: 4790), total oxidant status (TOS), total antioxidant capacity (TAC), catalase activity (CAT), and oxidative stress index (OSI) were measured. Receiver operating characteristic (ROC) curves and logistic regression were used to analyze biomarker sensitivity and risk association. Results: MLCK and NF-kB were significantly elevated in METH users compared to controls (p< 0.001*). TOS and OSI were higher, while TAC and CAT were lower in METH users (p< 0.001*). ROC analysis revealed MLCK (AUC = 0.978) and NF-kB (AUC = 0.959) as sensitive biomarkers for BBB dysfunction. Logistic regression indicated increased odds of memory impairment with elevated MLCK (OR = 1.246) and NF-kB (OR = 1.452), though these associations were not statistically significant (p > 0.05). Conclusions: Chronic METH use is associated with oxidative stress, inflammation, and increased BBB permeability, implicating MLCK and NF-kB as potential biomarkers for neurovascular damage and cognitive decline. Larger studies are warranted to confirm these associations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.